Abbott Launches GenAI Libre Assist to Predict Meal-Time Glucose Impact

The feature was launched at CES 2026 and is integrated within the Libre by Abbott mobile application.

Abbott has debuted Libre Assist, a generative artificial intelligence feature designed to help people with diabetes make informed meal decisions by predicting their glucose responses before consuming food.

The feature was launched at CES 2026 and is integrated within the Libre by Abbott mobile application.

Libre Assist allows users to input food information either through text or by uploading a photo. Using generative AI-based analysis, the system identifies ingredients and assigns a color-coded rating—green, yellow, or orange—indicating the anticipated glucose impact of the meal. The feature is accessible through the “Insights” tab within the Libre app.

A key component of Libre Assist is its closed-loop verification process. After a meal is consumed, the system compares its initial glucose prediction with real-time physiological data captured by Abbott’s Libre 3 Plus continuous glucose monitoring (CGM) sensor. This reconciliation process enables the system to validate predictions against actual glucose trends, creating what Abbott describes as a medically validated feedback loop.

The technical architecture of Libre Assist is built on two core elements: predictive modeling and sensor-based verification. The predictive layer relies on GenAI algorithms to assess food composition and estimate the impact of glucose on the body before consumption. The verification layer then integrates post-meal CGM data to evaluate prediction accuracy and refine feedback.

Abbott’s introduction of Libre Assist comes as healthcare organizations continue to take a cautious approach toward autonomous or “agentic” AI applications. According to 2025 data from KLAS Research, only 0.5% of reported healthcare AI use cases are categorized as agentic, with most health systems prioritizing lower-risk deployments such as ambient clinical documentation and revenue cycle workflows.

“People living with diabetes need more than apps that just log food and fall short of helping them with meal decisions,” said Marc Taub, vice president of technical operations for Abbott’s diabetes care business. He noted that Libre Assist was developed to provide predictive meal guidance supported by real-time glucose insights from Abbott’s CGM technology.

Libre Assist is offered at no additional cost to users and is available through the Libre by Abbott app on both Apple App Store and Google Play Store. The feature requires active user participation, including manual food input or photo capture, to generate predictions.

Stay tuned for more such updates on Digital Health News